SCHEMBL4656471

SCHEMBL4656471

Fc1nc(-c2cccnc2)cs1

nearest known ligand 0.67

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 11/20 0.67
AXL P30530 1/20 0.67
PBRM1 Q86U86 1/20 0.67
MKNK1 Q9BUB5 1/20 0.67
MKNK2 Q9HBH9 1/20 0.67
RAB9A P51151 5/20 0.63
NPC1 O15118 3/20 0.63
MEN1 O00255 1/20 0.58
MAPT P10636 1/20 0.58
KMT2A Q03164 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
KDM4E B2RXH2 1/20 0.58
ALDH1A1 P00352 1/20 0.58
MAPK1 P28482 1/20 0.56
TDP1 Q9NUW8 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6196239 0.80 CYP19A1 (1.00) CYP19A1AXLPBRM1MKNK1MKNK2
SCHEMBL30098510 0.80 CYP19A1 (0.69) CYP19A1AXLPBRM1MKNK1MKNK2
SCHEMBL23924237 0.80 CYP19A1 (0.69) CYP19A1AXLPBRM1MKNK1MKNK2
SCHEMBL128811 0.80 CYP19A1 (0.69) CYP19A1AXLPBRM1MKNK1MKNK2
SCHEMBL1807468 0.79 CYP19A1 (0.67) CYP19A1AXLPBRM1MKNK1MKNK2
Bromide SCHEMBL15689048 0.79 CYP19A1 (0.67) CYP19A1AXLPBRM1MKNK1MKNK2
SCHEMBL9571662 0.79 CYP19A1 (0.67) CYP19A1AXLPBRM1MKNK1MKNK2
SCHEMBL9090840 0.78 CYP19A1 (0.61) CYP19A1AXLPBRM1MKNK1MKNK2
SCHEMBL17014786 0.77 CYP19A1 (1.00) CYP19A1AXLPBRM1MKNK1MKNK2
SCHEMBL30128572 0.77 CYP19A1 (1.00) CYP19A1AXLPBRM1MKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1996565-A2 SUBSTITUTED AMINOTHIAZOLE DERIVATIVES WITH ANTI-HCV ACTIVITY Achillion Pharmaceuticals, Inc. (US) 2008-12-03 EP disclosed
WO-2007103550-A2 SUBSTITUTED AMINOTHIAZOLE DERIVATIVES WITH ANTI-HCV ACTIVITY ACHILLION PHARMACEUTICALS, INC. (US) 2007-09-13 WO disclosed